Filter results
Type
Audience
Last updated
Topics
-
Privacy notice for Medicare Urgent Care Clinics
Using our websites › Website privacy policy21 February 2025 - Find out how we manage the personal information collected about you when you visit a Medicare Urgent Care Clinic.
-
Life Saving Drugs Program – Fact sheet for patients
Resources › Publications26 April 2023 - Health professionals can print this fact sheet and give it to patients who are starting treatment under the Life Saving Drugs Program.
-
New aged care regulatory model: how it will work – Webinar
Resources › Webinars10 June 2025 - This webinar gave providers and workers an overview of the new aged care regulatory model, the new registration process and categories.
-
Serious allergic reactions to tick bites
Resources › Publications6 December 2022 - Symptoms, features and treatment of tick anaphylaxis.
-
Stoma Product Assessment Panel – B. Braun public summary document collection – October 2023
Resources › Publications16 June 2025 - This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in October 2023.
-
Providing naloxone under the Take Home Naloxone program
Our work › Take Home Naloxone program12 May 2025 - Learn more about providing naloxone as part of the Take Home Naloxone program initiative, and how to register as or apply to be a provider.
-
Transcript of Interview with Dan Searle, Physiotherapist
News and media11 August 2022 - A transcript of the interview between Deputy National Rural Health Commissioner Faye McMillan, and physiotherapist Dan Searle from the third issue of the Chief Allied Health Officer Newsletter.
-
New arrangements for migalastat (Galafold®) – information for prescribers
Resources › Publications3 June 2025 - This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.
-
Life Saving Drugs Program – Late infantile Batten disease (CLN2)
Resources › Publications11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for late-infantile onset Batten disease under the Life Saving Drugs Program.
-
AskMBS Advisory #1 – General practice services
Resources › Publications30 June 2025 - Advice for health providers and other users of the Medicare Benefits Schedule on the interpretation and application of MBS items, explanatory notes and associated legislation, to assist them in billing Medicare correctly.